SMS Pharmaceuticals Q4 Results
- BSE: 532815
- NSE: SMSPHARMA
- ISIN: INE812G01025
- Sector: Biotechnology & Drugs
BSE
335.25
-17.95 (-5.08%)
-17.95 (-5.08%)Volume9.65 K
Updated: Fri 13 Feb, 2026 | 15:29:26
NSE
336.75-14.05 (-4.01%)
-14.05 (-4.01%)Volume2.38 L
Updated: Fri 13 Feb, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - SMS Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 216.03 | 176.82 | 45.14% | 220.10 | -1.85% |
| Depreciation/ Amortization | 8.64 | 10.02 | -0.64% | 7.92 | 9.14% |
| Operating Income | 32.17 | 33.63 | 31.22% | 25.70 | 25.15% |
| Net Income | 20.32 | 23.47 | 11.37% | 17.28 | 17.57% |
| Other Operating Expenses Total | 7.44 | 10.19 | -51.24% | 6.70 | 11.06% |
| Net Income Before Taxes | 28.52 | 31.16 | 27.12% | 21.74 | 31.22% |
| Total Revenue | 248.20 | 210.45 | 43.17% | 245.80 | 0.98% |
| Selling/ General/ Admin Expenses Total | 26.63 | 21.05 | 42.83% | 22.93 | 16.12% |
| Diluted Normalized EPS | 2.39 | 2.59 | 11.07% | 2.05 | 16.56% |